Physician profile
Daniel Eli Penn
NPI 1528143377
$92,314.81
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $23K · 2021: $23K · 2022: $223.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $79,275.67 | 2019-2022 | |
| Endogastric Solutions, INC | $9,813.47 | 2019-2022 | |
| Mauna Kea Technologies, INC. | $1,244.16 | 2019-2021 | |
| Boston Scientific Corporation | $533.93 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $460.35 | 2019-2022 | |
| Olympus America INC. | $175.44 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $128.24 | 2019-2021 | |
| Janssen Biotech, INC. | $104.47 | 2020-2021 | |
| Vivus LLC | $97.19 | 2021-2022 | |
| Evoke Pharma, INC. | $79.04 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $76.50 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $59.08 | 2020-2021 | |
| Pfizer INC. | $57.47 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $42.89 | 2021 | |
| Celgene Corporation | $36.50 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $35.21 | 2021 | |
| Allergan, INC. | $34.85 | 2020 | |
| Alfasigma USA, INC. | $18.90 | 2020 | |
| Redhill Biopharma INC. | $15.82 | 2021 | |
| Endo Pharmaceuticals INC. | $14.81 | 2020 | |
| Romark Laboratories, Lc | $10.82 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Eli Penn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.